home / scout

Targets — browse / sort / filter (view)

One row per human protein target with names + key evidence. Click column headers to SORT; use the facets to FILTER (tier, activation pair, known aptamer, EV-Map). UniProt IDs link to the source. Default sort is evidence_priority — a DETERMINISTIC, reproducible score computed from harvested evidence (structure / disease / predicted-surface / EV-detection). Filter has_structure=1 for the core set: targets with a reported 3D structure (the requirement the Kd layer is built around).

Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target

id
UniProt accession (human). Links to uniprot.org.
gene_symbol
Gene symbol (e.g. ITGB3).
protein_name
Protein name (UniProt).
tier
Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
has_structure
1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
evidence_priority
DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
has_activation_state_pdb_pair
1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
in_cev_map
Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
has_known_aptamer
1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
opentargets_top_disease_score
Open Targets association score (0-1).
aptamer_count_pubmed
Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
aptamer_pmids
The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
surface_class
PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.

528 rows where has_cryoEM = 0, has_known_aptamer = 0 and surface_class = "A_surface" sorted by evidence_priority descending

✎ View and edit SQL

This data as json, CSV (advanced)

tier 2

  • Tier 1.5 385
  • Tier 1 143

in_cev_map 2

  • 0 348
  • 1 180

has_structure 2

  • 0 306
  • 1 222

surface_class 1

  • A_surface · 528 ✖

has_known_aptamer 1

  • - · 528 ✖

has_cryoEM 1

  • - · 528 ✖

has_activation_state_pdb_pair 1

  • 0 528
id gene_symbol protein_name tier evidence_priority ▲ has_structure surface_class pdb_count_total alphafold_mean_pLDDT has_cryoEM has_activation_state_pdb_pair activation_state_pdb_active activation_state_pdb_inactive has_known_aptamer aptamer_count_pubmed aptamer_pmids in_cev_map opentargets_top_disease_name opentargets_top_disease_score
P51795 CLCN5 H(+)/Cl(-) exchange transporter 5 Tier 1.5 0.955 1 A_surface 2 80.62 0 0     0 0   1 Dent disease type 1 0.850724240157394
O00571 DDX3X ATP-dependent RNA helicase DDX3X Tier 1 0.951 1 A_surface 17 72.19 0 0     0 0   1 X-linked non-syndromic intellectual disability 0.8362533125067105
P25189 MPZ Myelin protein P0 Tier 1.5 0.951 1 A_surface 2 81.69 0 0     0 0   1 Charcot-Marie-Tooth disease type 1B 0.8377022197539885
P54760 EPHB4 Ephrin type-B receptor 4 Tier 1 0.95 1 A_surface 23 82.0 0 0     0 0   1 Capillary malformation - arteriovenous malformation 0.8317426466005666
Q8WZA1 POMGNT1 Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 Tier 1 0.948 1 A_surface 10 89.88 0 0     0 0   1 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 0.826104223872448
P13473 LAMP2 Lysosome-associated membrane glycoprotein 2 Tier 1.5 0.948 1 A_surface 2 83.19 0 0     0 0   1 Glycogen Storage Disease Type 2b 0.8273010649608126
O94766 B3GAT3 Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 Tier 1 0.94 1 A_surface 3 92.56 0 0     0 0   1 Larsen-like syndrome, B3GAT3 type 0.7995331164339264
Q14118 DAG1 Dystroglycan 1 Tier 1 0.938 1 A_surface 8 68.19 0 0     0 0   1 autosomal recessive limb-girdle muscular dystrophy type 2P 0.7935290060634741
Q9UPN3 MACF1 Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 Tier 1 0.938 1 A_surface 3   0 0     0 0   1 lissencephaly 9 with complex brainstem malformation 0.7945569032416216
P08473 MME Neprilysin Tier 1 0.937 1 A_surface 16 96.19 0 0     0 0   1 Charcot-Marie-Tooth disease axonal type 2T 0.7912653398252156
P35916 FLT4 Vascular endothelial growth factor receptor 3 Tier 1 0.937 1 A_surface 2 72.44 0 0     0 0   1 lymphatic malformation 1 0.7904355931811005
O75880 SCO1 Cytochrome c oxidase assembly factor SCO1 Tier 1 0.935 1 A_surface 10 77.75 0 0     0 0   1 mitochondrial complex IV deficiency, nuclear type 4 0.7827872588103603
O94856 NFASC Neurofascin Tier 1.5 0.933 1 A_surface 2 76.31 0 0     0 0   1 neurodevelopmental disorder with central and peripheral motor dysfunction 0.7782432580663833
Q15746 MYLK Myosin light chain kinase, smooth muscle Tier 1.5 0.93 1 A_surface 7 65.88 0 0     0 0   1 aortic aneurysm, familial thoracic 7 0.7659842793171938
O95714 HERC2 E3 ubiquitin-protein ligase HERC2 Tier 1 0.925 1 A_surface 15   0 0     0 0   1 developmental delay with autism spectrum disorder and gait instability 0.74952129063985
Q02413 DSG1 Desmoglein-1 Tier 1.5 0.92 1 A_surface 1 62.06 0 0     0 0   1 severe dermatitis-multiple allergies-metabolic wasting syndrome 0.7335328506238418
Q9Y6N7 ROBO1 Roundabout homolog 1 Tier 1 0.897 1 A_surface 12 60.0 0 0     0 0   1 neurooculorenal syndrome 0.6567040910170603
Q13555 CAMK2G Calcium/calmodulin-dependent protein kinase type II subunit gamma Tier 1.5 0.891 1 A_surface 2 78.38 0 0     0 0   1 intellectual developmental disorder 59 0.6354497016986491
P31431 SDC4 Syndecan-4 Tier 1 0.885 1 A_surface 5 63.28 0 0     0 0   1 non-small cell lung carcinoma 0.6168120240815278
Q92956 TNFRSF14 Tumor necrosis factor receptor superfamily member 14 Tier 1.5 0.879 1 A_surface 8 79.94 0 0     0 0   1 diffuse large B-cell lymphoma 0.5983171413833771
P20701 ITGAL Integrin alpha-L Tier 1 0.877 1 A_surface 41 82.62 0 0     0 0   1 psoriasis 0.5899795223699872
P0DOY3 IGLC3 Immunoglobulin lambda constant 3 Tier 1 0.876 1 A_surface 4 96.06 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P01859 IGHG2 Immunoglobulin heavy constant gamma 2 Tier 1 0.876 1 A_surface 5 87.38 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P01857 IGHG1 Immunoglobulin heavy constant gamma 1 Tier 1 0.876 1 A_surface 100 86.69 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P01597 IGKV1-39 Immunoglobulin kappa variable 1-39 Tier 1.5 0.876 1 A_surface 2 90.5 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P01764 IGHV3-23 Immunoglobulin heavy variable 3-23 Tier 1.5 0.876 1 A_surface 6 91.0 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P23083 IGHV1-2 Immunoglobulin heavy variable 1-2 Tier 1.5 0.876 1 A_surface 1 91.75 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P01593 IGKV1D-33 Immunoglobulin kappa variable 1D-33 Tier 1.5 0.876 1 A_surface 6 90.88 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P06312 IGKV4-1 Immunoglobulin kappa variable 4-1 Tier 1.5 0.876 1 A_surface 10 90.62 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
Q10588 BST1 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 Tier 1 0.869 1 A_surface 6 89.62 0 0     0 0   1 Parkinson disease 0.5634966060310903
Q16513 PKN2 Serine/threonine-protein kinase N2 Tier 1 0.868 1 A_surface 4 71.44 0 0     0 0   1 neurodegenerative disease 0.5587297348479079
P12318 FCGR2A Low affinity immunoglobulin gamma Fc region receptor II-a Tier 1 0.866 1 A_surface 9 76.94 0 0     0 0   1 ulcerative colitis 0.5526669305497712
Q96D96 HVCN1 Voltage-gated hydrogen channel 1 Tier 1.5 0.865 1 A_surface 2 69.75 0 0     0 0   1 Joubert syndrome 0.5504227269701596
Q12913 PTPRJ Receptor-type tyrosine-protein phosphatase eta Tier 1 0.864 1 A_surface 5 77.75 0 0     0 0   1 neurodegenerative disease 0.54699134609967
Q9P1W8 SIRPG Signal-regulatory protein gamma Tier 1.5 0.864 1 A_surface 2 85.5 0 0     0 0   1 type 1 diabetes mellitus 0.5457344827318543
O15155 BET1 BET1 homolog Tier 1.5 0.864 1 A_surface 1 83.06 0 0     0 0   1 neurodegenerative disease 0.5468418315282804
P04439 HLA-A HLA class I histocompatibility antigen, A alpha chain Tier 1 0.863 1 A_surface 100 87.12 0 0     0 0   1 diffuse large B-cell lymphoma 0.5431777522591615
P35052 GPC1 Glypican-1 Tier 1 0.863 1 A_surface 4 82.5 0 0     0 0   1 COVID-19 0.5430103345490354
P29320 EPHA3 Ephrin type-A receptor 3 Tier 1 0.863 1 A_surface 28 80.75 0 0     0 0   1 medullary thyroid gland carcinoma 0.5426301743186921
P34741 SDC2 Syndecan-2 Tier 1.5 0.863 1 A_surface 1 60.84 0 0     0 0   1 COVID-19 0.5422254875204983
Q15811 ITSN1 Intersectin-1 Tier 1 0.859 1 A_surface 11 72.31 0 0     0 0   1 genetic disorder 0.5312614627352166
O00161 SNAP23 Synaptosomal-associated protein 23 Tier 1.5 0.859 1 A_surface 2 82.12 0 0     0 0   1 neurodegenerative disease 0.5288361677964304
P54756 EPHA5 Ephrin type-A receptor 5 Tier 1.5 0.858 1 A_surface 2 79.38 0 0     0 0   1 neurodegenerative disease 0.5261379875719714
P54762 EPHB1 Ephrin type-B receptor 1 Tier 1 0.856 1 A_surface 8 83.62 0 0     0 0   1 medullary thyroid gland carcinoma 0.5204553830376101
Q9HCM2 PLXNA4 Plexin-A4 Tier 1.5 0.856 1 A_surface 1 83.06 0 0     0 0   1 neurodegenerative disease 0.518371001420808
P15814 IGLL1 Immunoglobulin lambda-like polypeptide 1 Tier 1.5 0.85 1 A_surface 3 75.06 0 0     0 0   1 isolated agammaglobulinemia 0.4996673834185043
P78552 IL13RA1 Interleukin-13 receptor subunit alpha-1 Tier 1 0.846 1 A_surface 4 81.56 0 0     0 0   1 type 2 diabetes mellitus 0.48627783096767857
P18084 ITGB5 Integrin beta-5 Tier 1.5 0.846 1 A_surface 3 82.19 0 0     0 0   1 migraine disorder 0.48652455084344876
P19440 GGT1 Glutathione hydrolase 1 proenzyme Tier 1 0.845 1 A_surface 12 94.81 0 0     0 0   1 alcoholic liver disease 0.48228227774828414
P01889 HLA-B HLA class I histocompatibility antigen, B alpha chain Tier 1 0.845 1 A_surface 100 88.06 0 0     0 0   1 COVID-19 0.48417012135481613

Next page

Advanced export

JSON shape: default, array, newline-delimited

CSV options:

CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
 -- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
 -- Transparent weights over harvested evidence: structure 0.35, disease importance
 -- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
 -- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
 -- are predictions/detections, NOT measured EV-surface exposure.
 ROUND(
   0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
              WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
 + 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
 + 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
 + 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
 , 3) AS evidence_priority,
 (CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
 sc.surface_class,
 f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
 f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
 f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
 f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;
Powered by Datasette · Queries took 1253.907ms · Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target